Lincoln Pharmaceuticals standalone net profit declines 52.16% in the March 2017 quarter

Sales rise 1.30% to Rs 88.02 crore

Net profit of Lincoln Pharmaceuticals declined 52.16% to Rs 2.44 crore in the quarter ended March 2017 as against Rs 5.10 crore during the previous quarter ended March 2016. Sales rose 1.30% to Rs 88.02 crore in the quarter ended March 2017 as against Rs 86.89 crore during the previous quarter ended March 2016.

For the full year,net profit rose 16.23% to Rs 25.28 crore in the year ended March 2017 as against Rs 21.75 crore during the previous year ended March 2016. Sales declined 1.98% to Rs 304.66 crore in the year ended March 2017 as against Rs 310.81 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales88.0286.89 1 304.66310.81 -2 OPM %7.761.38 -13.8610.46 - PBDT4.678.12 -42 38.0933.27 14 PBT3.667.22 -49 34.2230.06 14 NP2.445.10 -52 25.2821.75 16

Powered by Capital Market - Live News